Genomenon develops software tools to rapidly and autonomously prioritize data points for decision-making.
Genomenon has raised $6.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in July 2026.
Genomenon's investors include Michigan Rise, BroadOak Capital Partners, Spring Mountain Capital, University of Michigan, Beringea.
Genomenon is headquartered in Ann Arbor, United States.
Genomenon develops software tools to rapidly and autonomously prioritize data points for decision-making.
Genomenon is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Genomenon — Funding & Investors." VCBacked, July 30, 2026, https://www.vcbacked.co/company/genomenon. Accessed October 31, 2026.
VCBacked. (2026). Genomenon — Funding & Investors. Retrieved October 31, 2026, from https://www.vcbacked.co/company/genomenon
{{cite web |title=Genomenon — Funding & Investors |url=https://www.vcbacked.co/company/genomenon |website=VCBacked |access-date=October 31, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated